It has been 12 yr since the publication of the last World Health Organization (WHO)
classification of tumours of the prostate and bladder. During this time, significant new …

Context Urothelial carcinoma can exhibit a wide range of variant morphologies. Many
variants present diagnostic challenges and carry clinical implications that inform prognosis …

In the past 10 years evidence for the clinical relevance of variant histology in urinary bladder
cancer has been increasing. This increase has resulted in new classifications of urothelial …

Context Variant histology of muscle-invasive (MIBC) and metastatic (mBC) bladder cancer
may define the cancer treatment modality and oncological outcomes. Objective To …

Bladder cancer can be classified histologically as urothelial or non-urothelial. Urothelial
cancer has a propensity for divergent differentiation, which has increasingly been …

Abstract The 2022 International Society of Urological Pathology (ISUP) Consensus
Conference on Urinary Bladder Cancer Working Group 2 was tasked to provide evidence …

Schistosoma-associated bladder cancer was believed, for several decades, to be a
completely unique entity of disease, different from urothelial cancer. This was probably due …

Adenocarcinoma is an uncommon malignancy in the urinary bladder which may arise
primarily in the bladder as well as secondarily from a number of other organs. Our aim is to …

Although approximately 80% of bladder cancer is caused by “conventional” urothelial
carcinoma (UC), the remaining 10% to 25% is the result of nonurothelial and “variants” of …

Background Urinary schistosomiasis and its severe complications, mainly bladder cancer,
are scarce in non-endemic areas. The deficiency in knowledge and clinical experience of …